Baxter International Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BAX research report →
Companywww.baxter.com
Baxter International Inc. , through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit.
- CEO
- Andrew Hider
- IPO
- 1981
- Employees
- 38,000
- HQ
- Deerfield, IL, US
Price Chart
Valuation
- Market Cap
- $9.67B
- P/E
- -8.78
- P/S
- 0.85
- P/B
- 1.60
- EV/EBITDA
- 23.31
- Div Yield
- 1.92%
Profitability
- Gross Margin
- 30.11%
- Op Margin
- -2.65%
- Net Margin
- -9.70%
- ROE
- -16.43%
- ROIC
- -1.77%
Growth & Income
- Revenue
- $11.24B · 5.72%
- Net Income
- $-957,000,000 · -47.46%
- EPS
- $-1.75 · -37.80%
- Op Income
- $-308,000,000
- FCF YoY
- -42.22%
Performance & Tape
- 52W High
- $32.04
- 52W Low
- $15.73
- 50D MA
- $17.39
- 200D MA
- $20.15
- Beta
- 0.62
- Avg Volume
- 8.70M
Get TickerSpark's AI analysis on BAX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 5, 26 | Wilkes David S. | other | 12,836 |
| May 5, 26 | Wendell Amy McBride | other | 12,836 |
| May 5, 26 | SCHLICHTING NANCY M | other | 12,836 |
| May 5, 26 | MORRISON PATRICIA | other | 12,836 |
| May 5, 26 | Shafer David Brent | other | 12,836 |
| May 5, 26 | McDonnell Michael R. | other | 12,836 |
| May 5, 26 | Craig Jeffrey A | other | 12,836 |
| May 5, 26 | Ampofo William A. II | other | 12,836 |
| Apr 1, 26 | Foster Julie | other | 0 |
| Apr 1, 26 | Foster Julie | other | 25,862 |
Our BAX Coverage
We haven't published any research on BAX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BAX Report →